G1 Therapeutics, Inc. revenue breakdown overview

G1 Therapeutics, Inc. revenue for the last year amounted to 82.51 M USD, the most of which — 46.34 M USD — came from its highest performing source at the moment, Novel Small Molecule Therapeutics, the year earlier bringing 31.34 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought G1 Therapeutics, Inc. 82.51 M USD, and the year before that — 51.30 M USD.